NCT05168813 Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern Status COMPLETED Phase PHASE2/PHASE3
NCT05168709 Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction Status COMPLETED Phase PHASE4
NCT05167279 A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19 Status COMPLETED Phase PHASE1
NCT05167253 A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines. Status WITHDRAWN Phase PHASE1
NCT05166876 Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19 Status TERMINATED Phase PHASE2
NCT05165979 Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05165966 Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19 Status COMPLETED Phase PHASE4
NCT05165953 Relationship Between Bronchial Asthma and COVID-19 Infection in Adults: Clinical and Laboratory Assessment Status COMPLETED Phase N/A
NCT05165732 Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19 Status SUSPENDED Phase PHASE4
NCT05164744 Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors Status RECRUITING Phase N/A
NCT05164133 A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 Status COMPLETED Phase PHASE1
NCT05164120 Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19 Status COMPLETED Phase PHASE2
NCT05163730 Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel Status COMPLETED Phase NA
NCT05163613 Use of Low-frequency Magnetic Fields in the Hybrid Treatment of COVID-19 Patients Status UNKNOWN Phase NA
NCT05162495 Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection. Status UNKNOWN Phase NA
NCT05162365 A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 Status TERMINATED Phase PHASE1/PHASE2